Evidence map›Paper›PMID 36831543›Full record

ReviewCancers2023

Ablative Therapy in Non-HCC Liver Malignancy.

Tyler P Robinson, Travis Pebror, Matthew E Krosin, Leonidas G Koniaris

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Tyler P RobinsonDepartment of Surgery, Indiana University, Indianapolis, IN 46202, USA.
Travis PebrorDepartment of Interventional Radiology, Indiana University, Indianapolis, IN 46202, USA.
Matthew E KrosinDepartment of Interventional Radiology, Indiana University, Indianapolis, IN 46202, USA.
Leonidas G KoniarisDepartment of Surgery, Indiana University, Indianapolis, IN 46202, USA.
Indiana University – Purdue University Indianapolis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surgical extirpation of liver tumors remains a proven approach in the management of metastatic tumors to the liver, particularly those of colorectal origin. Ablative, non-resective therapies are an increasingly attractive primary therapy for liver tumors as they are generally better tolerated and result in far less morbidity and mortality. Ablative therapies preserve greater normal liver parenchyma allowing better post-treatment liver function and are particularly appropriate for treating subsequent liver-specific tumor recurrence. This article reviews the current status of ablative therapies for non-hepatocellular liver tumors with a discussion of many of the clinically available approaches.

Indexed as

cryotherapyelectrochemotherapyhigh intensity focused ultrasoundIrreversible Electroporationlaser-induced thermotherapyliver malignancymicrowave ablationpercutaneous ethanol injectionphotodynamic therapyradiofrequency ablationstereotactic body radiotherapy

Identifiers

PMID36831543
PMCPMC9954041
OpenAlexW4320729457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.